SECOND AMENDMENT TO LETTER AGREEMENTLetter Agreement • January 30th, 2006 • Novoste Corp /Fl/ • Electromedical & electrotherapeutic apparatus
Contract Type FiledJanuary 30th, 2006 Company IndustryTHIS SECOND AMENDMENT TO LETTER AGREEMENT (the “Amendment”) is entered into effective the 1st day of February, 2006, by Novoste Corporation, a Florida corporation (hereinafter referred to as the “Company”) and Daniel G. Hall (hereinafter referred to as the “Executive”). The Company and Executive are hereinafter referred to collectively, as the “Parties.”
AMENDMENT NO. 3 TO MARKETING REPRESENTATION AGREEMENTMarketing Representation Agreement • January 30th, 2006 • Novoste Corp /Fl/ • Electromedical & electrotherapeutic apparatus • Georgia
Contract Type FiledJanuary 30th, 2006 Company Industry JurisdictionThis Amendment No. 3 to Marketing Representation Agreement (the “Amendment No. 3”) is made this 27th day of January, 2006, by and among (i) Novoste Corporation, a Florida corporation with its principal place of business at 4350 International Boulevard, Norcross, Georgia 30093 (“Novoste”), (ii) Best Vascular, Inc., a Delaware corporation with its principal place of business at 7643 Fullerton Road, Springfield, Virginia 22153 (“Representative”), and (iii) Best Medical International, Inc., a Virginia corporation which is an affiliate of Representative, with its principal place of business at 7643 Fullerton Road, Springfield, Virginia 22153 (“BMI”);